Early detection and characterization of Alzheimer's disease in clinical scenarios using Bioprofile concepts and K-means

Alzheimer's Disease (AD) is the most common neurodegenerative disease in elderly people. There is a need for objective means to detect AD early to allow targeted interventions and to monitor response to treatment. To help clinicians in these tasks, we propose the creation of the Bioprofile of AD. A Bioprofile should reveal key patterns of a disease in the subject's biodata. We applied k-means clustering to data features taken from the ADNI database to divide the subjects into pathologic and non-pathologic groups in five clinical scenarios. The preliminary results confirm previous findings and show that there is an important AD pattern in the biodata of controls, AD, and Mild Cognitive Impairment (MCI) patients. Furthermore, the Bioprofile could help in the early detection of AD at the MCI stage since it divided the MCI subjects into groups with different rates of conversion to AD.

[1]  Henrik Zetterberg,et al.  Alzheimer's disease , 2006, The Lancet.

[2]  Roberto Hornero,et al.  Nonlinear analysis of electroencephalogram and magnetoencephalogram recordings in patients with Alzheimer's disease , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[3]  A. Dale,et al.  Subregional neuroanatomical change as a biomarker for Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[4]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[5]  Rui Xu,et al.  Clustering Algorithms in Biomedical Research: A Review , 2010, IEEE Reviews in Biomedical Engineering.

[6]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[7]  J. Trojanowski,et al.  Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. , 2010, Archives of neurology.

[8]  R. Petersen,et al.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.

[9]  Roman Filipovych,et al.  Semi-supervised pattern classification of medical images: Application to mild cognitive impairment (MCI) , 2011, NeuroImage.

[10]  Nick C Fox,et al.  The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.

[11]  Jeffrey L. Cummings,et al.  Integrating ADNI results into Alzheimer's disease drug development programs 1 1 Prepared for a special issue of Neurobiology of Aging on the Alzheimer's Disease Neuroimaging Initiative (ADNI). , 2010, Neurobiology of Aging.

[12]  Lingfen Sun,et al.  A Framework for Bioprofile Analysis Over Grid , 2009, IEEE Systems Journal.

[13]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.